Observational studyMedicina (Kaunas, Lithuania)2026

Circulating miR-221/222 and Serum IL-23 in Treatment-Naïve Multiple Sclerosis: A Case-Control Study.

Ummu Serpil Sarı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.